Targeted Duo Wins Again in BRAF-Mutant Colorectal Cancer

(MedPage Today) — SAN FRANCISCO — Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated metastatic colorectal cancer led to a significant improvement in overall response rate (ORR), according…

Source link : https://www.medpagetoday.com/meetingcoverage/ascogi/119298

Author :

Publish date : 2026-01-06 19:27:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Targeted Duo Wins Again in BRAF-Mutant Colorectal Cancer

Early humans may have begun butchering elephants 1.8 million years ago

Sleep, Women, and Tau; Prenatal COVID and the Brain; Why FDA Rejected MS Drug

Related Posts

Next DSM Insights; FDA Reviewing Non-Stimulant ADHD Drug; 10M People Microdosing

Viral and Nonviral NICU Infection Rates Diverged During the COVID Pandemic

NIH Data Misused for ‘Race Science’; RFK Jr.’s Autism Committee; NIH Panels at Risk

Study Suggests Some Tap Water May Raise Blood Pressure

Juvenile Localized Scleroderma: MMF Matches Methotrexate

AI model from Google’s DeepMind reads recipe for life in DNA

Next DSM Insights; FDA Reviewing Non-Stimulant ADHD Drug; 10M People Microdosing

Viral and Nonviral NICU Infection Rates Diverged During the COVID Pandemic

NIH Data Misused for ‘Race Science’; RFK Jr.’s Autism Committee; NIH Panels at Risk

Study Suggests Some Tap Water May Raise Blood Pressure

Juvenile Localized Scleroderma: MMF Matches Methotrexate

AI model from Google’s DeepMind reads recipe for life in DNA

The Epstein-Berr virus infects most of us – but why do only some get very ill?

Ancient humans were seafaring far earlier than we realised

Categories

Archives